Amarantus Bioscience Holdings Inc (AMBS)

[breezy1]

/ Begin Quote "We note that Eli Lilly acquired the Amyvid test by acquiring Avid Radiopharmaceuticals in 2010 for $300 million upfront and $500 million in backend consideration. The total deal price of $800 million is 25X the current market value for all of Amarantus BioScience Holdings, Inc., which includes the Amarantus Therapeutics division currently developing a mesencephalic astrocyte-derived neurotrophic factor (OTCPK:MANF) for the treatment of Parkinson's disease and other ischemic disorders." End Quote

Maybe some Swiss Francs,

Amarantus' LymPro Could Be A Game-Changer For Alzheimer's Diagnosis

http://seekingalpha.com/article/1347691-amarantus-lympro-could-be-a-game-changer-for-alzheimers-diagnosis